Influence of 0.1 minimum alveolar concentration of sevoflurane, desflurane and isoflurane on dynamic ventilatory response to hypercapnia in humans M. VAN 
Summary
To assess the effects and site of action of a subanaesthetic concentration of isoflurane, desflurane and sevoflurane (0.1 minimum alveolar concentration (MAC)) on respiratory control, we measured the ventilatory response to square wave changes in ! ′ against a background of normoxia. Using the computer steered "endtidal forcing system", 2 min of steady state ventilation were followed by a step increase in ! ′ (1-1.5 kPa). This level was maintained for 8 min, followed by a step decrease to the original value for another 8 min. Each hypercapnic response was separated into a fast, peripheral component and a slow, central component, characterized by a time constant, carbon dioxide sensitivity, time delay and off-set. We studied 25 healthy volunteers; they performed 2-3 studies without and 2-3 studies during inhalation of the anaesthetic agent. Level of sedation was scored using a subjective seven-point scale from 0 (: alert and awake) to 6 (unrousable). In the isoflurane (16 subjects, 33 control, 37 drug studies) and sevoflurane (15 subjects, 40 control, 41 drug studies) studies, peripheral carbon dioxide sensitivity was reduced by approximately 45% and approximately 27% (ANOVA, P : 0.05 vs control), respectively, without affecting central carbon dioxide sensitivity or apnoeic threshold. In the desflurane study (16 subjects, 36 control, 37 drug studies), no significant effect was observed for any of the variables measured. A significant relation was observed between sedation score and change from control in central carbon dioxide sensitivities in the isoflurane and desflurane studies and in the change in the ratio peripheral carbon dioxide sensitivity over total carbon dioxide sensitivity in the sevoflurane studies. At the highest level of sedation observed (score 3-arousal state comparable with "light sleep"-in three subjects) these latter variables differed significantly from those in the other observed sedation levels (scores 1 and 2-a state of drowsiness). We conclude that 0.1 MAC of isoflurane and sevoflurane depressed the peripheral chemoreflex loop, without affecting the central chemoreflex loop. Desflurane at the same MAC showed no effect on peripheral and central carbon dioxide sensitivity. When the level of sedation was considered, our data suggested that at levels of sedation comparable with sleep, a depressive effect of all three anaesthetics was observed on the central chemoreflex loop. (Br. J. Anaesth. 1998; 80: 174-182) Keywords: anaesthetics volatile, desflurane; anaesthetics volatile, isoflurane; anaesthetics volatile, sevoflurane; ventilation, hypoxic response; hypoxaemia Sevoflurane and desflurane are two new inhalation anaesthetics. Earlier studies from our laboratory showed that in healthy volunteers, desflurane at 0.1 minimal alveolar concentration (MAC) did not affect the ventilatory response to normocapnic hypoxia but decreased significantly the response to asphyxia (hypercapnic hypoxia).
1 Sevoflurane at 0.1 MAC caused a reduction in the hypoxic response by approximately 30%.
2 Similar MAC fractions of isoflurane and halothane produced a more marked decrease in the hypoxic response (50% or more) in an equivalent group of healthy subjects. 3 4 Results of studies on the influence of 0.1 MAC of halothane and isoflurane on the ventilatory response to inhaled carbon dioxide were in agreement with the results of the hypoxic studies.
3 4 Moreover, carbon dioxide studies revealed a selective depressant effect of 0.1 MAC of halothane and isoflurane on the peripheral chemoreflex loop. None of the anaesthetics tested showed a significant effect on carbon dioxide sensitivity of the central chemoreceptors.
In order to study the influence of 0.1 MAC of desflurane and sevoflurane on the carbon dioxide related output of the peripheral and central chemoreflex loops, we determined ventilatory responses to square-wave changes in end-tidal carbon dioxide tension
against a background of normoxia. The ventilatory responses, measured on a breath-bybreath basis were then partitioned into a fast, peripheral and a slow, central component using a two-compartment model. 5 6 
Subjects and methods
We studied 25 healthy volunteers (12 women, 13 men, aged 22-37 yr), with no history of smoking, drug or alcohol abuse. The study was approved by the Leiden MAARTEN VAN University Committee on Medical Ethics and informed consent was obtained before the study. Subjects were unfamiliar with respiratory physiology but received information on the nature of the study. All had participated in several studies on respiratory physiology in our laboratory. Therefore, a test session was not required. Subjects were asked to refrain from stimulants and depressants for at least 12 h before the study.
During the study, subjects were in a semirecumbent position (135Њ between lower extremities and thorax). Soft music was played and subjects were instructed to keep their eyes closed throughout the studies. An oronasal mask (Vital Signs, USA) was fitted before the experiment started. Airway gas flow was measured with a pneumotachograph (Fleisch, Switzerland) connected to a differential pressure transducer (model 270, Hewlett Packard, USA) and integrated electronically to yield a volume signal. This signal was calibrated with a motor-driven piston pump. The pneumotachograph was connected to a T-piece. One arm of the T-piece received a gas mixture with a flow of 50 litre min 91 from a gas mixing system that consisted of three mass flow controllers (type F201, Bronkhorst High Tec, The Netherlands) with which the flow of oxygen, carbon dioxide and nitrogen could be set individually at a desired level. A PDP 11/23 microcomputer (Digital Equipment Corporation, Maynard, USA) provided control signals to the mass flow controllers, so that the composition of the inspiratory gas mixture could be adjusted to force the end-tidal carbon dioxide and oxygen partial pressures to follow a specific pattern in time. When appropriate, part of the nitrogen (5 litre min
91
) was bypassed through the isoflurane, sevoflurane or desflurane vaporizer. During the initial part of the study, the vaporizer was kept in the "off" position. Inspiratory and expiratory concentrations of oxygen and carbon dioxide were measured with a gas monitor (Datex Multicap, Finland) by paramagnetic and infrared analysis, respectively. The gas monitor was calibrated with gas mixtures of known concentrations. Each subject performed 2-3 studies without and 2-3 studies during inhalation of the anaesthetic agent. Control studies always preceded drug studies. Before we started a drug experiment we allowed an equilibration period of 20 min for isoflurane and 15 min for sevoflurane and desflurane after the appropriate end-tidal concentration had been reached. The target end-tidal concentrations used were 0.125%, 0.72% and 0.22% (approximately 0.1 MAC) for isoflurane, desflurane and sevoflurane, respectively. Throughout the studies, end-tidal concentrations were maintained at target levels by manipulation of the vaporizer by one of the investigators (M. vd E., E. S. or A. D.).
Sixteen subjects participated in the isoflurane and desflurane studies and 15 in the sevoflurane study. Seven subjects participated in all three studies. A single anaesthetic was tested on a particular morning session. Sessions were at least 2 weeks apart. The results of the isoflurane studies of eight subjects have been published previously. P ′ in humans is described by:
( 1 ) where G P : carbon dioxide sensitivity of the peripheral chemoreflex loop; G C : carbon dioxide sensitivity of the central chemoreflex loop; and B : apnoeic threshold or extrapolated 2 CO E P ′ of the steady-state ventilatory response to carbon dioxide at zero VI. The sum of G P and G C is total carbon dioxide sensitivity (G TOT ).
For analysis of the dynamic response of ventilation, we used a two-compartment model 5 6 :
where τ P and τ C : time constants of the peripheral and central chemoreflex loops, respectively; V P (t) and V C (t) : outputs of the peripheral and central chemoreflex loops, respectively; To model τ C of the ventilatory on-transient (τ ON ) to be different from that of the off-transient (τ OFF ), τ C is written as:
In most experiments a small drift in ventilation was present. We therefore included a drift term (Ct) in our model. The total ventilatory response VI(t) is made up of the contributions of the central and peripheral chemoreflex loops and Ct:
The parameters of the model were estimated by fitting the model to the breath-by-breath data with a least-squares method. To obtain optimal time delays a "grid search" was applied. All combinations of D P and D C , with increments of 1 s and with D P ഛ D C were tried until a minimum in the residual sum of squares was found. The minimum time delay was chosen arbitrarily to be 1 s, and τ P was constrained to be at least 0.3 s.
SCORING FOR SEDATION AND EXCLUSION CRITERIA
At the start and end of each hypercapnic study, we recorded the central nervous system arousal state by a subjective six-point observer's assessment of alertness/ sedation (LOAA/S) scale (table 1) . Data were discarded when the LOAA/S score was not 0 in the control studies, irregular breathing, coughing or an apparent change in the arousal state (for example as observed by restlessness) occurred in any of the studies.
STATISTICAL ANALYSIS
For each volatile agent, we determined the significance of differences between the control and drug studies by two-way analysis of variance (ANOVA) on parameters G P , G C , G P /G TOT (ratio) and B using a fixed model. To obtain information on the relationship between sedation score and the difference between drug and control parameters (⌬) we performed a linear regression analysis of ⌬G P , ⌬G C and ⌬G P /G TOT (⌬ratio) on sedation score. Further, we determined for each anaesthetic the significance of differences between sedation scores by ANOVA on ⌬G P , ⌬G C and ⌬ratio with post hoc multiple comparisons using NewmanKeuls test. Probability levels :0.05 were considered significant. All values are mean (SD), unless otherwise stated.
Results
All subjects completed the study without side effects. A total of 235 2 CO E ventilation P ′ 9 responses were obtained. Eleven studies were discarded because of irregular breathing (four control and seven drug studies, of which isoflurane two, desflurane two and sevoflurane three).
ISOFLURANE STUDIES
Thirty-three control and 37 isoflurane studies were included in the analysis. End-tidal isoflurane concentrations were 0.13 (0.04)% in the drug studies. The LOAA/S scores were 0 in the control studies for all subjects. In the isoflurane studies, scores were 1 in six, 2 in seven and 3 in three subjects. Isoflurane at 0.1 MAC caused peripheral carbon dioxide sensitivity to decrease by 45% (P : 0.003), without affecting central carbon dioxide sensitivity or apnoeic threshold (table  2) . These changes caused the ratio of peripheral carbon dioxide sensitivity to total carbon dioxide sensitivity (G P /(G P ; G C )) to decrease by 35% (P:0.01).
SEVOFLURANE STUDIES
Forty control and 41 sevoflurane studies were included in the analysis. End-tidal sevoflurane concentrations were 0.22 (0.04)% in the drug studies. The LOAA/S scores were 0 in the control studies for all subjects. In the sevoflurane studies, scores were 1 in six, 2 in six and 3 in three subjects. During sevoflurane inhalation, peripheral carbon dioxide sensitivity decreased by 27% (P:0.02). Central carbon dioxide sensitivity, ratio and apnoeic threshold were not affected by 0.1 MAC of sevoflurane. The typical fits to the data of two studies of one subject are shown in figure 1.
DESFLURANE STUDIES
Thirty-six control and 37 desflurane studies were included in the analysis. End-tidal desflurane concentrations were 0.70 (0.04)% in the drug studies. The LOAA/S scores were 0 in the control studies for all subjects. In the desflurane studies, scores were 1 in six, 2 in seven and 3 in three subjects. The model fits of a control and desflurane experiment of a subject are shown in figure 1. They indicate no effect on the peripheral or central chemoreflex loop. None of the estimated parameters differed significantly between control and desflurane studies (table 2) .
In figure 2 , scatter diagrams for G P , G C and ratio are given for all three anaesthetics.
INFLUENCE OF LEVEL OF SEDATION
Regression analysis revealed a significant relation between LOAA/S score and the difference in central carbon dioxide sensitivity between drug and control (⌬G C ) in the isoflurane and desflurane studies. The value of ⌬G C was smallest in the group with LOAA/S score 3 (P : 0.05; see figure 3 ). In the sevoflurane studies, we observed a significant relation between ⌬ratio and LOAA/S score with ⌬ratio greatest in the group with LOAA/S score 3 (P : 0.05; see figure 3 ). It is of interest to note that subjects with an LOAA/S score of 3 were three females that had participated in all three anaesthetic studies. Their LOAA/S scores were similar in the anaesthetic studies. Exclusion of their data from the analysis would not have affected the conclusion drawn from this study considerably (see fig. 4 ).
Discussion
Knill and colleagues were the first to study the effects of low concentrations of inhalation anaesthetics on the regulation of breathing in humans. [7] [8] [9] [10] In the late 1970s and early 1980s, they tested the effects of halothane, enflurane and isoflurane using several imposed chemical stimuli. Their studies led to the, still generally accepted, conclusion that inhalation anaesthetics selectively impair all responses mediated by the peripheral chemoreceptors at subanaesthetic concentrations (0.05-0.1 MAC). In order to study the different components of the ventilatory control system, Knill and colleagues used several tests. Using a carbon dioxide rebreathing technique to study the "central" ventilatory response to inhaled carbon dioxide, they observed no depression with 0.1 MAC halothane and isoflurane but approximately 25% depression with 0.1 MAC of enflurane. [7] [8] [9] To selectively study the peripheral chemoreflex loop they determined the ventilatory response to a gradual decrease in 2 O E P ′ over 8-10 min (a so-called "ramp hypoxic step") and to moderate isocapnic metabolic acidosis. [7] [8] [9] [10] Hypoxic studies showed a 60% reduction in the ventilatory response with all three anaesthetics at 0.1 MAC; the response to metabolic acidosis was reduced by 60% with 0.1 MAC of halothane. These studies indicated that at least halothane and isoflurane, at 0.1 MAC, affect ventilatory control selectively via an effect on the peripheral chemoreflex loop without an effect on the central chemoreflex loop or pathways common to both loops.
Some of the techniques used by Knill and colleagues have recently come under criticism. The carbon dioxide rebreathing technique, although simple in use, leads to results that are often difficult to interpret, as factors other than those under study determine outcome (such as initial concentration of carbon dioxide in the bag and arterial or end-tidal PCO 2 ; see Dahan and colleagues 11 and Berkenbosch and colleagues 12 for an analysis of the rebreathing technique). In this respect it is interesting that the results from rebreathing tests in the studies of Knill and colleagues were not uniform for all three anaesthetics. Temp, Henson and Ward demonstrated that the ramp hypoxic test does not allow adequate time for full expression of the hypoxic response from the peripheral chemoreceptors. 13 Tests that allow a more rapid decrease in 2 O E P ′ (step hypoxic test) are better suited for this purpose and, furthermore, enable the description of the depressant effects of hypoxia.
Despite the important results of the studies of Knill's group it took his personal request and approximately 20 yr before researchers from five independent laboratories investigated the influences of volatile agents on the ventilatory response to imposed chemical stimuli in humans.
14 The availability of hypoxic and hypercapnic tests that give results with less problems in interpretation (compared with the carbon dioxide rebreathing test and the ramp hypoxic test) is probably one of the main reasons. In table 3, data of hypoxic studies from the recent literature are summarized. The results of three institutions indicate an appreciable depressant effect of halothane, enflurane, isoflurane and sevoflurane on the acute hypoxic response to an isocapnic step decrease in
2-4 15-21 With respect to isoflurane, the results from UCLA and the Karolinska Institute indicate little or only a modest effect on the hypoxic response. 13 22-24 26 To explain these differences we have to take into account the significant differences in the design of the studies. For example, in contrast with the hypoxic studies from the Karolinska Institute and Edinburgh, 16 20 22-25 all those performed in Oxford, UCLA and Leiden had an increased baseline 2 CO E P ′ of 0.1-0.3 kPa.
3 4 13 15 17-19 21 26 Some of the hypoxic studies from the Karolinska Institute and Edinburgh were not performed under isocapnic conditions or allowed differences in 2 CO E P ′ between control and drug studies. 16 22-25 One study from Oxford and both from UCLA had an approach to prevent subjects from falling "asleep". 13 18 26 However, we believe that these differences only partly explain the discrepancies in study outcomes.
In comparison with hypoxic studies, studies that investigate the influence of anaesthetics on the ventilatory response to inhaled carbon dioxide are scarce. Previously, we compared the effects of 0.1 MAC of halothane and isoflurane, and observed a 20-25% reduction in steady-state normoxic ventilatory carbon dioxide sensitivity. 3 4 Analysis of the dynamic ventilatory response with the same two-compartment model used in this study revealed that this could be attributed to an effect within the peripheral chemoreflex loop (G P reduced by approximately 50%). These results are in agreement with those of the hypoxic studies obtained from three of the five institutions (table 3) . In contrast, a hypercapnic study from the Karolinska Institute showed no effect of 0.2% end-tidal isoflurane on carbon dioxide sensitivity (anaesthetic response : 0.96 of control response (ns)).
EQUI-MAC-FRACTION DATA
In this study, isoflurane and sevoflurane at 0.1 MAC significantly reduced peripheral carbon dioxide sensitivity without affecting central carbon dioxide sensitivity and the apnoeic threshold. This indicates a selective depressant effect of both anaesthetics on the peripheral chemoreflex loop. These results are in agreement with our hypoxic studies in which we observed a reduction in the acute hypoxic ventilatory response by approximately the same magnitude at 0.1 MAC.
2 4 Desflurane did not influence the ventilatory response to carbon dioxide significantly. With respect to G P , a decrease was observed in nine Figure 2 Scatter diagrams of the mean ventilatory carbon dioxide sensitivities of the peripheral (G P ) and central (G C ) chemoreflex loops and the ratio G P /G TOT (G TOT : G P ; G C ). A: Isoflurane study. Each subject has similar symbols in the three diagrams. B : Sevoflurane study; C : desflurane study. of 16 subjects (there was a trend towards a reduction by approximately 15%). In a previous study we were unable to demonstrate an effect of 0.1 MAC of desflurane on the hypoxic response at normocapnia. 1 However, in that study the ventilatory response to asphyxia was reduced by approximately 30%. This indicates that the peripheral chemoreflex loop does not remain completely unaffected by 0.1 MAC of desflurane. A type II error, therefore, may not be excluded in our current study. The reason for the difference between desflurane and the other two anaesthetics remains unclear. At higher concentrations, desflurane is known to increase sympathetic outflow and irritate the airways. 27 28 We did not observe any signs related to airway irritation or sympathetic activation (for example coughing, breathholding, sneezing or tachycardia). However, subclinical activation of the sympathetic system and systemic release of catecholamines during hypercapnia and hypoxia may be a possible explanation for the absence of depression of the normoxic ventilatory response to carbon dioxide. It is of interest to note that nitrous oxide, another sympathomimetic agent, at 0.2 MAC influences the ventilatory responses to hypoxia and hypercapnia in a manner similar to desflurane. 29 At this point, we have to keep in mind that when considering the LOAA/S scores as a measure of the CNS arousal state of individual subjects (equisedative data) the above stated conclusions (drawn from equi-MAC-fraction data) need some modification (see below).
SITE OF ACTION
Isoflurane and sevoflurane affected the ventilatory response to carbon dioxide through an exclusive action on parts of the peripheral chemoreflex loop (these are: peripheral chemoreceptors, sinus nerve and sites in the CNS related to the processing of peripheral input). In a previous study we performed the "wash-in" of isoflurane during steady-state isocapnic-hypoxia-driven ventilation.
4 Eighty percent of the reduction in ventilation occurred within Figure 3 Influence of Leiden observer's assessment of alertness/sedation (LOAA/S) scale on the change from control (⌬) in central carbon dioxide sensitivity (G C ), peripheral carbon dioxide sensitivity (G P ) and ratio (G P /(G P ; G C )). Regression analysis revealed a significant relation between ∆G C and LOAA/S in the isoflurane and desflurane studies, and between ∆ratio and LOAA/S in the sevoflurane studies. The closed data points denote LOAA/S scores significantly different from other scores (P : 0.05, ANOVA). A : All scores combined. Values are mean (SEM). between scores 1 and 2), and therefore conclusions drawn from these data should be made with caution. We observed a significant relation between LOAA/S score and ⌬G C in the isoflurane and desflurane studies and ⌬ratio in the sevoflurane studies. Further analysis revealed that ⌬G C and ⌬ratio were significantly different in subjects with LOAA/S score 3 compared with those with scores 1 and 2 in the isoflurane and desflurane studies and sevoflurane studies, respectively ( fig. 3) . In other words, the three subjects with LOAA/S score 3 showed greater depression of G C compared with G P . Although we used equipotent concentrations in terms of MAC, these three subjects, all female, had a deeper level of sedation. Inter-individual differences in pharmacodynamics and possibly also differences between the sexes are the most likely explanation for the deeper level of sedation. Our small sample suggests that sedation by anaesthetics to levels sufficient to block the perception of or reaction to a light auditory stimulus (that is LOAA/S score 9 2, an arousal state comparable with light sleep 2 ) results in depression of the hypercapnic ventilatory response at sites within the central chemoreflex loop additional to sites within the peripheral chemoreflex loop. We stress the importance of stating the level of sedation of individual subjects when reporting data on ventilatory control and agents that affect the arousal state, because conclusions drawn from data at equi-MACfractions may differ significantly from those drawn at equi-sedative levels.
In summary, 0.1 MAC of isoflurane and sevoflurane, causing a CNS arousal state such that our subjects remained able to respond to a light auditory stimuli, affected the ventilatory control system via an exclusive effect on the peripheral chemoreflex loop. These observations are an extension of earlier findings of Knill and colleagues on isoflurane and halothane. At these concentrations and sedation levels, desflurane seemed exempt from an effect on ventilatory control. Our study suggests that at deeper levels of sedation, all three anaesthetics affected ventilatory control at sites within the central chemoreflex loop. Further studies are needed to investigate the influence of sedation of volatile anaesthetics, as opposed to the MAC of anaesthetics, on ventilatory control.
